PITTSBURGH, April 25, 2024 /PRNewswire/ -- An exciting advancement for the specialty pharmacy industry, KEEP announced a strategic partnership with PANTHERx Rare, a leader in rare disease product patient access and support services in the US. This collaboration is set to enhance the home-based therapy experience for patients living with rare and orphan conditions..

匹兹堡，2024年4月25日/PRNewswire/——KEEP宣布与PANTHERx Rare建立战略合作伙伴关系，PANTHERx Rare是美国罕见病产品患者获取和支持服务的领导者。这一合作旨在增强罕见病和孤儿患者的家庭治疗体验。。

The partnership leverages KEEP's innovative technology, including its Modern Medicine Cabinet and the KARE by KEEP Patient Insight Platform, with PANTHERx's award- winning RxARECARE® program supporting people living with rare conditions. The synergy improves medication management, broadens access to critical treatments, and delivers -data-driven healthcare solutions directly in patients' homes..

该合作关系利用KEEP的创新技术，包括其现代医学柜和KARE by KEEP Patient Insight平台，以及PANTHERx屡获殊荣的RxARECARE®计划，为患有罕见疾病的人提供支持。这种协同作用改善了药物管理，扩大了重症治疗的范围，并直接在患者家中提供了数据驱动的医疗保健解决方案。。

By integrating KEEP's technology with PANTHERx's RxARECARE® pharmacy services, the partnership will improve the effectiveness of home-based specialty therapies while using real-time data capture and analyses to inform better patient support and care strategies. This enables tailored interventions to address individual patient needs like never before, increasing the quality of life and treatment outcomes for rare disease patients..

通过将KEEP的技术与PANTHERx的RxARECARE®药房服务相结合，该合作伙伴关系将提高家庭专业治疗的有效性，同时使用实时数据采集和分析来为更好的患者支持和护理策略提供信息。这使得量身定制的干预措施能够前所未有地满足患者的个人需求，提高罕见病患者的生活质量和治疗效果。。

Richard Faris, Ph.D., R.Ph., Chief Strategy and Growth Officer for PANTHERx® Rare Pharmacy expressed his enthusiasm: 'Our partnership with KEEP is a game-changer for the rare disease community. Together, we can redefine how specialty medications are managed at home, making a real difference in the lives of our patients.'.

PANTHERx®Rare Pharmacy首席战略和增长官Richard Faris博士表示了他的热情：“我们与KEEP的合作关系是罕见病社区的游戏规则改变者。总之，我们可以重新定义在家中如何管理专业药物，从而真正改变患者的生活。”。

Jeff Wandzura, CEO of KEEP, shared his excitement: 'This collaboration is about bringing two leaders together to push the boundaries of what's possible in patient care. With PANTHERx's expertise and our technology, we are crafting a future in which each patient feels supported and confident in managing their medications in their own home.'.

KEEP首席执行官杰夫·旺祖拉（JeffWandzura）分享了他的兴奋：“这次合作是为了让两位领导者走到一起，推动病人护理领域的发展。凭借PANTHERx的专业知识和我们的技术，我们正在打造一个未来，让每位患者在自己的家中管理药物时都感到支持和自信。”。

The partnership plans to deepen the understanding of medication management in the home setting, fostering unique and positive patient experiences and journeys. Together, PANTHERx and KEEP reaffirm their collaborative vision to pave the way for the future of patient-centric healthcare solutions, ensuring a brighter, healthier future for all..

该伙伴关系计划加深对家庭环境中药物管理的理解，培养独特而积极的患者体验和旅程。PANTHERx和KEEP共同重申了他们的合作愿景，为以患者为中心的医疗保健解决方案的未来铺平道路，确保所有人都有一个更光明、更健康的未来。。

About KEEP Labs:

关于KEEP Labs：

KEEP Labs is transforming the specialty medication experience in the home by passively capturing dosing events to drive personalized, real-time interventions. The KARE by KEEP Patient Insight Platform provides patient support programs, life science organizations, pharmacies and clinicians with the ability to identify, triage and support individuals based on real-world utilization data in the home for all specialty dosage forms..

KEEP Labs正在通过被动捕获剂量事件来推动个性化的实时干预，从而改变家庭中的专业药物治疗体验。KARE by KEEP Patient Insight平台为患者支持计划、生命科学组织、药店和临床医生提供了根据家庭中所有专业剂型的实际使用数据识别、分类和支持个人的能力。。

The company was founded by two dads who were looking for a smart way to store prescription medication. The platform has been recognized as a TIME Best Invention and a CES Innovation Honoree. For more information on how KARE by KEEP is optimizing the specialty medication journey, visit www.KAREbyKEEP.com. .

这家公司是由两位父亲创立的，他们正在寻找一种聪明的方式来储存处方药。该平台被评为“时代最佳发明奖”和“消费电子产品创新奖”。有关KEEP的KARE如何优化专业药物治疗过程的更多信息，请访问www.KAREbyKEEP.com。

About PANTHERx Rare:

关于PANTHERx稀有：

PANTHERx Rare is a dual-accredited specialty pharmacy focused on rare and orphan disease, distributing several orphan products and providing access and support services to those needing them most. PANTHERx transforms lives by delivering medicine breakthroughs, clinical excellence, and access solutions to people living with rare and devastating conditions.

PANTHERx Rare是一家双重认证的专业药店，专注于罕见病和孤儿病，分销几种孤儿产品，并为最需要的人提供获取和支持服务。PANTHERx通过为患有罕见和毁灭性疾病的人提供医学突破、临床卓越和获取解决方案来改变生活。

While each rare condition affects few people, together all rare diseases impact an estimated 25 to 30 million Americans. Currently over 7,000 rare diseases have been identified and more than 90% of rare diseases are still without an FDA-approved treatment.  Changes in federal policy and advances in science have led to a surge in FDA orphan drug approvals, providing tremendous hope to the rare disease community..

虽然每种罕见病对很少人产生影响，但所有罕见病加在一起，估计会影响2500万至3000万美国人。目前，已鉴定出7000多种罕见疾病，超过90%的罕见疾病仍未获得FDA批准的治疗。联邦政策的变化和科学的进步导致FDA孤儿药批准激增，为罕见病社区带来了巨大的希望。。

PANTHERx is a dual-accredited specialty pharmacy, holding distinctions in rare disease including the Accreditation Commission for Health Care (ACHC) Distinction in Orphan Drugs and Utilization Review Accreditation Commission (URAC) Rare Disease Center of Excellence.  As a pharmacy focused on patient satisfaction, PANTHERx is now a six-time winner of the prestigious MMIT Patient Choice Award, including the 2023 honor.

PANTHERx是一家获得双重认证的专业药房，在罕见病方面拥有卓越成就，包括孤儿药卫生保健认证委员会（ACHC）和利用审查认证委员会（URAC）罕见病卓越中心。作为一家专注于患者满意度的药店，PANTHERx现已六次荣获著名的MMIT患者选择奖，其中包括2023年的荣誉。

PANTHERx is headquartered in Pittsburgh, Pennsylvania and is licensed in all 50 states and US territories..

PANTHERx总部位于宾夕法尼亚州匹兹堡，并在美国所有50个州和地区获得许可。。